Aditya Birla Sun Life CRISIL Liquid Overnight ETF

An open-ended Exchange Traded Fund replicating the CRISIL Liquid Overnight Index. A relatively low interest rate risk and relatively low credit risk

February 2026

Passive Debt Index Scheme
Investment Objective
The investment objective of the Scheme is to generate returns corresponding to the total returns of the securities as represented by the CRISIL Overnight Fund AI Index before expenses, subject to tracking errors. The Scheme does not guarantee/indicate any returns. There can be no assurance or guarantee that the investment objective of the scheme will be achieved.
Fund Category: Debt ETFs
Fund Snapshot
Date of Allotment : Mar 13, 2023
Benchmark: CRISIL Liquid Overnight Index
Fund Manager - Ms. Sunaina Da Cunha
Managing the Fund Since: March 03, 2023 Experience in Managing the Fund: 3.0 Years
Fund Manager - Mr. Sanjay Pawar
Managing the Fund Since: March 03, 2023 Experience in Managing the Fund: 3.0 Years
Load Structure (as % of NAV) (Incl. for SIP)
Entry Load: NIL
Exit Load: NIL
AUM as on February 27, 2026 (in ₹Crore)
Month End AUM 27.88
Monthly Average AUM 27.97
Total Expense Ratio (TER)
Regular 0.43%
Including additional expenses and goods and service tax on management fees.
NAV as on February 27, 2026
NAV 1000.00
Tracking Error
Tracking Error Regular 0.02%
Portfolio Holdings as on February 27, 2026
( • Top Ten Holdings - Issuerwise)
Sector/Issuer Name
% to Net Assets

Net Cash and Cash Equivalent

100.00%

Grand Total

100.00%

Miscellaneous includes securities with exposure of less than 0.01%

Scheme Name

Aditya Birla Sun Life CRISIL Liquid Overnight ETF
An open-ended Exchange Traded Fund replicating the CRISIL Liquid Overnight Index.
A relatively low interest rate risk and relatively low credit risk
This product is suitable for investors who are seeking*:
  • Short term income with liquidity
  • An open ended Exchange Traded Fund that seeks to track CRISIL Liquid Overnight Index
Risk-o-meter
Benchmark Risk-o-meter
CRISIL Liquid Overnight Index
*Investors should consult their financial advisors if in doubt whether the product is suitable for them.